Showing results (121-130 of 272) with videos related to

Sort By:
Pageof 28
Clinical Genitourinary Cancer|May 17, 2022
Testis Cancer Care in North Carolina: Implications for Real-World Evidence and Cancer SurveillanceStephen McMahon, Xi Zhou, Christopher D Baggett, et al.
PET Clinics|January 10, 2024
PET/Computed Tomography Transformation of Oncology: Kidney and Urinary Tract CancersJorge D Oldan, Jennifer A Schroeder, Jean Hoffman-Censits, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|August 2, 2007
Phase 1/2 clinical trial of interferon alpha2b and weekly liposome-encapsulated all-trans retinoic acid in patients with advanced renal cell carcinomaStephen A Boorjian, Matthew I Milowsky, Jodi Kaplan, et al.
European Urology|September 3, 2024
Clinical Implications of Basic Research: Exploring the Transformative Potential of Spatial 'Omics in Uro-oncologySandy Figiel, Anthony Bates, David A Braun, et al.
The Journal of Urology|July 28, 2020
Impairment and Longitudinal Recovery of Older Adults Treated with Radical Cystectomy for Muscle Invasive Bladder CancerChelsea K Osterman, Allison M Deal, Hannah McCloskey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 2013
Phase II study of gemcitabine, carboplatin, and bevacizumab in patients with advanced unresectable or metastatic urothelial cancerArjun V Balar, Andrea B Apolo, Irina Ostrovnaya, et al.
BJU International|August 17, 2010
Hypoxia-inducible factor and mammalian target of rapamycin pathway markers in urothelial carcinoma of the bladder: possible therapeutic implicationsSatish K Tickoo, Matthew I Milowsky, Nitin Dhar, et al.
JCO Precision Oncology|July 6, 2023
Phase II Trial of Olaparib in Patients With Metastatic Urothelial Cancer Harboring DNA Damage Response Gene AlterationsDeborah B Doroshow, Peter H O'Donnell, Jean H Hoffman-Censits, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 7, 2026
Online support needs and preferences for survivors of testicular cancer: a qualitative descriptive studySonam J Shah, Samuel Tate, Mary W Dunn, et al.
The Journal of Clinical Investigation|January 16, 2024
FGFR inhibition augments anti-PD-1 efficacy in murine FGFR3-mutant bladder cancer by abrogating immunosuppressionAtsushi Okato, Takanobu Utsumi, Michela Ranieri, et al.
Pageof 28